Anti‐CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial. (12th March 2018) - Schetelig, Johannes; Link, Cornelia S.; Stuhler, Gernot; Wagner, Eva M.; Hänel, Mathias; Kobbe, Guido; Böttcher, Sebastian; Kreuzer, Karl‐Anton; Middeke, Jan M.; Sockel, Katja; Teipel, Raphael; von Bonin, Malte; et al.